Concepedia

Patrick Jimonet

PJ

Statistics

Publications

17

Citations

621

H-Index

12

Active since

1987

Affiliations

Sanofi (France)(Current)

Smiths Detection (France)

Patrick Jimonet is an author at Sanofi (France) specializing in pharmacology, medicinal chemistry, and neuropharmacology.

Publications per year

1987–2004

17

Publications

17

Riluzole Series. Synthesis and in Vivo “Antiglutamate” Activity of 6-Substituted-2-benzothiazolamines and 3-Substituted-2-imino-benzothiazolines

Patrick Jimonet, F. AUDIAU, Michel Barreau et al. · Journal of Medicinal Chemistry · 1999 · 232 citations

Medicine, Medicinal Chemistry, Pharmacology +10

RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.

Thierry Canton, Böhme Ga, Alain Boireau et al. · PubMed · 2001 · 68 citations

Medicine, Neuroscience, Pharmacology +17

RPR 119990, a Novel α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis

Thierry Canton, Georg Andrees Böhme, Alain Boireau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 46 citations

Medicine, Neuroscience, Pharmacology +12

Strategies for designing GPCR-focused libraries and screening sets.

Patrick Jimonet, Robert De Jager · PubMed · 2004 · 41 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic Acid (RPR117824): Selective Anticonvulsive and Neuroprotective AMPA Antagonist

Serge Mignani, Georg Andrees Böhme, Guillaume Birraux et al. · Bioorganic & Medicinal Chemistry · 2002 · 35 citations

Medicine, Neuroscience, Pharmacology +10

1–5 of 17